Unexplained weight loss (UWL) is a common yet perplexing clinical presentation that often poses a diagnostic challenge. It can be an indicator of a serious underlying condition, and therefore, necessitates a comprehensive, systematic evaluation. This article seeks to provide a comprehensive approach to evaluating UWL in clinical practice.
The first step is a thorough history and physical examination, focusing on the duration, severity of weight loss, and associated symptoms. It is important to rule out intentional weight loss due to changes in diet, exercise, or psychiatric conditions. The use of medications that can cause weight loss should also be considered.
Following the initial assessment, basic laboratory studies should be conducted. These may include a complete blood count, metabolic panel, liver function tests, thyroid function tests, and urinalysis. Imaging studies, such as chest radiography or abdominal ultrasound, may be considered based on the clinical suspicion.
If the above evaluations are inconclusive, more specialized investigations may be warranted, including endoscopic procedures, CT scans, or MRI. These tests can help identify occult malignancies, chronic infections, or systemic diseases that could be causing weight loss.
The management of UWL should be directed towards the underlying cause. In cases where no specific cause is identified, symptomatic treatment and regular monitoring may be required. Nutritional support plays a crucial role in managing these patients.
Evaluating unexplained weight loss requires a comprehensive and systematic approach. While it can be challenging, a thorough history, physical examination, and appropriate use of laboratory and imaging studies can often lead to the diagnosis. In cases where the cause remains elusive, regular follow-up and symptomatic management are essential, ensuring the best possible outcome for the patient.
1.
Heavy Cannabis Use Tied to Increased Head and Neck Cancer Risk
2.
Early Results for Anorexia Nervosa with Psilocybin.
3.
Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer
4.
Colorectal Cancer Screening Uptake Tripled in 45-49 Age Group
5.
A new device enhances liquid biopsy.
1.
Uncovering the Hidden Signs: How to Recognize the Early Symptoms of Colon Cancer
2.
Personalized Cancer Vaccines: The Next Frontier in Precision Oncology
3.
MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed
4.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
5.
Clinical Pharmacology of Ferroptosis-Modulating Anticancer Pharmacotherapy
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
3.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
4.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
5.
From Guidelines to Practice: Hematology
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation